Humana Inc. (HUM) Price Prediction 2026–2050

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell.

The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers.

Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc.

in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Inc. (HUM) is a healthcare company with a current price of $307.95 and a market cap of $36.97B. It ranks 386 in market capitalization among peers.

The stock carries an annualized volatility of 50% and a mid-range technical picture that sits within a broad price context.

Long-run forecasts point to a bullish trajectory, with projected average prices rising meaningfully in the coming years. The forecast indicates multi-year appreciation, with projected averages of $598.60 by 2030, $1,585.68 by 2040, and $3,528.87 by 2050, underscoring a strong upward price path over the horizon.

Overall, the outlook suggests ongoing upside potential, though actual results will depend on future market conditions and company performance.

2030 forecast: avg $598.60, min $450.15, max $855.82; ROI 94.4%; sentiment BULLISH. The mid-to-late decade outlook points to a strong upside, with a rising average price and a bullish stance reflected in the forecast.

2040 forecast: avg $1,585.68, min $1,046.46, max $2,600.71; ROI 414.9%; sentiment BULLISH. The longer horizon envisions substantial gains and continued bullish momentum, aligned with the multi-year expansion in the forecast.

2050 forecast: avg $3,528.87, min $2,108.12, max $6,292.34; ROI 1045.9%; sentiment BULLISH. These figures illustrate a continued, pronounced upward trajectory over the long term, though they remain estimates and are not guaranteed.